Richard Parkes analyst BNP

Currently out of the existing stock ratings of Richard Parkes, 5 are a BUY (71.43%), 1 are a HOLD (14.29%), 1 are a SELL (14.29%).

Richard Parkes

Work Performance Price Targets & Ratings Chart

Analyst Richard Parkes, currently employed at BNP, carries an average stock price target met ratio of 50% that have a potential upside of 2.56% achieved within 38 days.

Richard Parkes’s has documented 11 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NVO, Novo Nordisk A/S at 27-Jun-2022.

Wall Street Analyst Richard Parkes

Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 6/27/2022. The price target of $52.88 was fulfilled within 37 days with a profit of $2.85 (5.11%) receiving and performance score of 1.38.

Average potential price target upside

AZN AstraZeneca PLC ADR NVO Novo Nordisk A/S NVS Novartis AG ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

1 months 26 days ago
(13-Sep-2024)

1/11 (9.09%)

$82.61 (131.40%)

2587

Buy

$95

$23.58 (33.02%)

$66

2 months 27 days ago
(12-Aug-2024)

6/7 (85.71%)

$12.48 (15.12%)

360

Buy

$85

$13.58 (19.01%)

$80

5 months 9 days ago
(30-May-2024)

4/4 (100%)

$8.23 (10.72%)

390

Buy

$82

$10.58 (14.81%)

$80

6 months 13 days ago
(26-Apr-2024)

4/4 (100%)

$6.83 (9.09%)

296

Buy

$85

$13.58 (19.01%)

9 months 16 days ago
(23-Jan-2024)

1/11 (9.09%)

$19.26 (29.30%)

210

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Richard Parkes?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?